Copenhagen, Denmark—10 August 2025 – FluoGuide A/S has released highlights from its live-recorded...
Category - Pharmaceuticals
Sanofi’s rilzabrutinib earns orphan designation in the EU for...
The European Medicines Agency (EMA) has granted orphan drug designation to rilzabrutinib, Sanofi’s...
Kite to Acquire Interius BioTherapeutics to Advance In Vivo...
Kite, a Gilead Company (Nasdaq: GILD), today announced that it has entered into a definitive...